{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T06:11:58Z","timestamp":1771999918067,"version":"3.50.1"},"reference-count":14,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2007,5,3]],"date-time":"2007-05-03T00:00:00Z","timestamp":1178150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Transplantation"],"published-print":{"date-parts":[[2007,9]]},"abstract":"<jats:p><jats:bold>Abstract:\u2002<\/jats:bold> Background: Cardiovascular (CV) disease is the foremost cause of mortality and an important cause of morbidity in renal transplant recipients. The disease burden is likely to increase as older patients are accepted for transplantation. The outcome of these high\u2010CV risk patients after renal transplantation, especially with known pre\u2010transplant coronary artery disease (CAD), has not been studied. Hence, we looked at the CV outcome in patients with known pre\u2010transplant CAD. Methods: All renal transplants performed between 1998 and 2002 at our center, followed up to 2005, were divided into high\u2010 and low\u2010risk groups, based on the presence of one or more of the following: pre\u2010transplant angina, myocardial infarction, and positive coronary angiogram. The two groups were compared for post\u2010transplant cardiac events and patient and graft survival. The factors predictive of post\u2010transplant cardiac events were also determined by Cox\u2010regression multivariate analysis. Results: Forty\u2010five patients (10.5%), out of 429, had post\u2010transplant cardiac events; 31.3% in the high risk, and 6.5% in the low\u2010risk group (p\u2003=\u20030.001). Five\u2010yr patient survival was lower in the high\u2010risk group (82.8% vs. 93.1%, p\u2003=\u20030.004), while five\u2010yr overall graft survival and death censored graft survival were statistically not different (74.8% vs. 84.1%, p\u2003=\u20030.08 and 87.3% vs. 90%, p\u2003=\u20030.25). Forty\u2010one percent of patients who were treated with angioplasty plus stenting or bypass graft prior to transplantation had post\u2010transplant cardiac events, as compared with 28% of those without intervention in the high\u2010risk group and 6.5% of patients in the low\u2010risk group (p\u2003=\u20030.001). Age, pre\u2010transplant cardiac disease, arrhythmias, and low\u2010ejection fraction (\u226440%) were significant independent predictors of post\u2010transplant cardiac events. Conclusion: Post\u2010transplant survival of high\u2010CV risk patients (with known CAD) is lower than that of low\u2010risk recipients but remains acceptable. Cardiac interventions may reduce perioperative risk but do not reduce the probability of post\u2010transplant cardiac events to that of low\u2010risk group.<\/jats:p>","DOI":"10.1111\/j.1399-0012.2007.00695.x","type":"journal-article","created":{"date-parts":[[2007,5,9]],"date-time":"2007-05-09T04:32:33Z","timestamp":1178685153000},"page":"609-614","source":"Crossref","is-referenced-by-count":40,"title":["Renal transplant outcome in high\u2010cardiovascular risk recipients"],"prefix":"10.1111","volume":"21","author":[{"given":"Tarun K","family":"Jeloka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanley","family":"Fenton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Cattran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Schiff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl","family":"Cardella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Cole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,5,3]]},"reference":[{"key":"e_1_2_5_2_2","first-page":"5","article-title":"Treatment of end\u2010stage organ failure in Canada","author":"Canadian Organ Replacement Register (CORR)","year":"2003","journal-title":"Canadian Institute of Health Information"},{"key":"e_1_2_5_3_2","unstructured":"Renal Data System USRDS2005. Annual data reporthttp:\/\/www.usrds.org."},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.1998.v32.pm9820470"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V71158"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199912023412303"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V1191735"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00751.x"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000160764.35083.B8"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2004.00573.x"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)93010-K"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200109271-00003"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2005.05.014"},{"key":"e_1_2_5_14_2","first-page":"380","article-title":"The influence of pre\u2010operative electrocardiographic abnormalities and cardiovascular risk factors on patient and graft survival following renal transplantation","volume":"15","author":"Woo YM","year":"2002","journal-title":"J Nephrol"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/13.6.1499"}],"container-title":["Clinical Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-0012.2007.00695.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-0012.2007.00695.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T22:23:26Z","timestamp":1696890206000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-0012.2007.00695.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,3]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["10.1111\/j.1399-0012.2007.00695.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-0012.2007.00695.x","archive":["Portico"],"relation":{},"ISSN":["0902-0063","1399-0012"],"issn-type":[{"value":"0902-0063","type":"print"},{"value":"1399-0012","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,3]]}}}